Relapsed High-Risk Medulloblastoma: Stable Disease after Two Years of Treatment with Somatostatin Analog - Case Report.

Abstract

Cerebellar medulloblastoma in adults is an uncommon disease. Therefore, most information comes from the pediatric population, and the treatment for relapses is based on series and case reports. The expression of somatostatin receptors has been identified in most medulloblastoma patients, and preclinical experience has shown a promissory response to… (More)
DOI: 10.7759/cureus.446

Topics

4 Figures and Tables

Cite this paper

@article{Galvis2016RelapsedHM, title={Relapsed High-Risk Medulloblastoma: Stable Disease after Two Years of Treatment with Somatostatin Analog - Case Report.}, author={Luisa Galvis and Diego Gonzalez and Carlos Bonilla}, journal={Cureus}, year={2016}, volume={8 1}, pages={e446} }